Method for selective derivatization of oligohistidine sequence of recombinant proteins

US9441010B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9441010-B2
Application numberUS-201313962426-A
CountryUS
Kind codeB2
Filing dateAug 8, 2013
Priority dateAug 8, 2012
Publication dateSep 13, 2016
Grant dateSep 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and compositions for the selective derivatization of a oligohistidine-tagged recombinant protein. A modifying compound comprised of an imidazole reactive group, a linker, and a ligating group is contacted with the recombinant protein, and a cooperative bond forms between the ligating group and the oligohistidine tag in the presence of a metal cation, and a covalent bond forms between the imidazole reactive group and an imidazole ring of the oligohistidine tag followed by the concomitant separation of the imidazole reactive group from the linker. Addition of a metal chelator results in the dissociation of the ligating group and the oligohistidine tag.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for the selective derivatization of a recombinant protein, the method comprising: contacting a recombinant protein comprising an oligohistidine tag with a modifying compound in the presence of a metal cation, wherein the modifying compound comprises the formula X 1 X 2 X 3 , wherein: X 1 is an imidazole reactive group comprising the structure represented by the formula: wherein R1 is an electron withdrawing group and R2 is a connector connecting the imidazole reactive group to X 2 ; X 2 is a linking group; and X 3 is at least one ligating group; wherein said contacting is performed under conditions sufficient for the formation of a bond between X 3 and the oligohistidine tag utilizing said metal cation, and under conditions sufficient for the formation of a covalent bond between X 1 and an imidazole ring of the oligohistidine tag and concomitant separation of X 1 and X 2 ; and breaking the bond between X 3 and the oligohistidine tag using a metal chelator. 2. The method of claim 1 , wherein said electron withdrawing group is selected from the group consisting of an acyl group, an ester group, an alkylsulfonyl group, an arylsulfonyl group, a nitro group, a cyano group, a carbamoyl group, and combinations thereof. 3. The method of claim 1 , wherein X 3 comprises a plurality of ligating groups. 4. The method of claim 1 , wherein X 3 is selected from the group consisting of a primary amino group, a secondary amino group, a teriary amino group, a carboxy group, an imino group, a phenol group, a catechol group, a hydroxamate group, a sulfamido group, a phosphoryl group, an imidazolyl group, a thiazolyl group, an oxazolyl group, a pyridazolyl group, a pyridyl group, a thiol group, and combinations thereof. 5. The method of claim 1 , wherein said metal cation is selected from the group consisting of Ni 2+ , Zn 2+ , Cu 2+ , Fe 2+ , Co 2+ , Co 3+ , Fe 3+ , and combinations thereof. 6. The method of claim 1 , wherein said conditions sufficient for the formation of a bond between X 3 and the oligohistidine tag comprise the presence of an additive. 7. The method of claim 6 , wherein the additive comprises imidazole, N-methylimidazole, or N-alkylimidazole. 8. A compound for the selective derivatization of a recombinant protein comprising an oligohistidine tag, the compound comprising: the formula X 1 X 2 X 3 , wherein X 1 is an imidazole reactive group comprising the structure represented by the formula: wherein R1 is an electron withdrawing group and R2 is a connector connecting the imidazole reactive group to X 2 ; X 2 is a linking group; and X 3 is at least one ligating group; wherein said compound is adapted to form a bond between X 3 and a oligohistidine tag of a recombinant protein in the presence of a metal cation, and further adapted to form a covalent bond between X 1 and an imidazole ring of the oligohistidine tag. 9. The compound of claim 8 , wherein X 3 comprises a plurality of ligating groups. 10. The compound of claim 8 , wherein X 3 is selected from the group consisting of a primary amino group, a secondary amino group, a teriary amino group, a carboxy group, a phosphoryl group, an imidazolyl group, a thiazolyl group, an oxazolyl group, a pyridazolyl group, a pyridyl group, and combinations thereof. 11. A method for the selective derivatization of a recombinant protein, the method comprising: contacting a recombinant protein comprising an oligohistidine tag with a modifying compound in the presence of a metal cation, wherein the modifying compound comprises the formula X 1 X 2 X 3 , wherein X 1 is an imidazole reactive group comprising the structure represented by the formula below: wherein R1 is an electron withdrawing group selected from the group consisting of an acyl group, an ester group, an alkylsulfonyl group, an arylsulfonyl group, a nitro group, a cyano group, and combinations thereof, and R2 is a linker to a linking group; X 2 is said linking group; and X 3 is a plurality of ligating groups each selected from the group consisting of a primary amino group, a secondary amino group, a teriary amino group, a carboxy group, a phosphoryl group, an imidazolyl group, a thiazolyl group, an oxazolyl group, a pyridazolyl group, a pyridyl group, and combinations thereof; and further wherein said contacting is performed under conditions sufficient for the formation of a bond between X 3 and the oligohistidine tag utilizing a metal cation, and under conditions sufficient for the formation of a covalent bond between X 1 and an imidazole ring of the oligohistidine tag and concomitant separation of X 1 and X 2 ; and breaking the bond between X 3 and the oligohistidine tag using a metal chelator.

Assignees

Inventors

Classifications

  • C07K1/107Primary

    by chemical modification of precursor peptides · CPC title

  • C07K1/13Primary

    Labelling of peptides · CPC title

  • the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9441010B2 cover?
Methods and compositions for the selective derivatization of a oligohistidine-tagged recombinant protein. A modifying compound comprised of an imidazole reactive group, a linker, and a ligating group is contacted with the recombinant protein, and a cooperative bond forms between the ligating group and the oligohistidine tag in the presence of a metal cation, and a covalent bond forms between th…
Who is the assignee on this patent?
Melman Artem, Univ Clarkson
What technology area does this patent fall under?
Primary CPC classification C07K1/107. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).